Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2016-10-07

Clinical Trial Update: Precision Cell Immunotherapy Combined With Chemotherapy in Advanced Lung Cancer [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update describes a Phase 1/Phase 2 study evaluating precision cell immunotherapy combined with chemotherapy in patients with advanced lung c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Chemotherapy (chemotherapy)
  • Precision Cell Immunotherapy

Snippet

Sponsor: Ningbo Cancer Hospital | Conditions: Precision Cell Immunotherapy, Chemotherapy | Phase 1, Phase 2 | Status: UNKNOWN